Authors:
Celis, H
Thijs, L
Staessen, JA
Birkenhager, WH
Bulpitt, CJ
de Leeuw, PW
Leonetti, G
Nachev, C
Tuomilehto, J
Fagard, RH
Citation: H. Celis et al., Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial, J HUM HYPER, 15(9), 2001, pp. 613-618
Authors:
Celis, H
Fagard, RH
Staessen, JA
Thijs, L
Citation: H. Celis et al., Risk and benefit of treatment of isolated systolic hypertension in the elderly: evidence from the Systolic Hypertension in Europe Trial, CURR OPIN C, 16(6), 2001, pp. 342-348
Authors:
Oliva, G
Romero, I
Ayala, G
Barrios-Jacobo, I
Celis, H
Citation: G. Oliva et al., Characterization of the inorganic pyrophosphatase from the pathogenic bacterium Helicobacter pylori, ARCH MICROB, 174(1-2), 2000, pp. 104-110
Authors:
Gasowski, J
Staessen, JA
Celis, H
Fagard, RH
Thijs, L
Birkenhager, WH
Bulpitt, CJ
Fletcher, AE
Arabidze, GG
de Leeuw, P
Dollery, CT
Duggan, J
Kawecka-Jaszcz, K
Leonetti, G
Nachev, C
Safar, M
Rodico, JL
Rosenfeld, J
Seux, ML
Tuomilehto, J
Webster, J
Yodfat, Y
Citation: J. Gasowski et al., Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress, J HUM HYPER, 13(2), 1999, pp. 135-145
Authors:
Tuomilehto, J
Rastenyte, D
Birkenhager, WH
Thijs, L
Antikainen, R
Bulpitt, CJ
Fletcher, AE
Forette, F
Goldhaber, A
Palatini, P
Sarti, C
Fagard, R
Staessen, JA
Arabidze, GG
Carrageta, M
Celis, H
Kocemba, J
Leonetti, G
Nachev, C
O'Brien, ET
Ritz, E
Rodicio, JL
Rosenfeld, J
Heyrman, J
Stibbe, G
Van den Haute, H
Yodfat, Y
De Cort, P
Hubner, GE
Citation: J. Tuomilehto et al., Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension, N ENG J MED, 340(9), 1999, pp. 677-684